Are patients with comorbidities more prone to sequalae in severe COVID-19

被引：0

作者：

Daga, Mradul Kumar ^{[1
]}

Mawari, Govind ^{[1
]}

Chand, Siddharth ^{[1
]}

Aarthi, J. ^{[1
]}

Raghu, R. V. ^{[1
]}

Kumar, Naresh ^{[1
]}

机构：

[1] Maulana Azad Med Coll, Dept Med, New Delhi 110002, India

来源：

INDIAN JOURNAL OF MEDICAL SPECIALITIES | 2021年 / 12卷 / 03期

关键词：

Corticosteroids; COVID-19; sequalae; ACUTE RESPIRATORY SYNDROME; FIBROSIS;

D O I：

10.4103/injms.injms_37_21

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Majority hospital admission in COVID-19 is because of pneumonia. Few develop progressive and permanent pulmonary fibrosis. Here, we present three patients of severe COVID-19 pneumonia requiring intensive care unit care. Computed tomography (CT) of the chest of these patients revealed multiple areas of lung involvement at the 4th week of illness. Follow-up CT scan and pulmonary function test were done after 5 months to look for residual changes. Pulmonary fibrosis induced by COVID-19 is being documented. We need long-term follow-up studies to observe the clinical and radiological course of fibrosis. Corticosteroids and antifibrotic agents in such cases are being looked into.

引用

页码：161 / 164

页数：4

共 19 条

[1] Post COVID-19 fibrosis, an emerging complication of SARS-CoV-2 infection [J].

Alhiyari, Mousa Ahmad ;

Ata, Fateen ;

Alghizzawi, Mohd Islam ;

Bilal, Ammara Bint, I ;

Abdulhadi, Ahmad Salih ;

Yousaf, Zohaib .

IDCASES, 2021, 23

[2] Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System JACC Review Topic of the Week [J].

Brojakowska, Agnieszka ;

Narula, Jagat ;

Shimony, Rony ;

Bander, Jeffrey .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (24) :3085-3095

[3] Mechanical Ventilation-associated Lung Fibrosis in Acute Respiratory Distress Syndrome A Significant Contributor to Poor Outcome [J].

Cabrera-Benitez, Nuria E. ;

Laffey, John G. ;

Parotto, Matteo ;

Spieth, Peter M. ;

Villar, Jesus ;

Zhang, Haibo ;

Slutsky, Arthur S. .

ANESTHESIOLOGY, 2014, 121 (01) :189-198

[4] Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis [J].

Collins, Bridget F. ;

Raghu, Ganesh .

EUROPEAN RESPIRATORY REVIEW, 2019, 28 (153)

[5] COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead [J].

Gentile, Francesco ;

Aimo, Alberto ;

Forfori, Francesco ;

Catapano, Giosue ;

Clemente, Alberto ;

Cademartiri, Filippo ;

Emdin, Michele ;

Giannoni, Alberto .

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (13) :1442-1446

[6] The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors [J].

Hui, DS ;

Wong, KT ;

Ko, FW ;

Tam, LS ;

Chan, DP ;

Woo, J ;

Sung, JJY .

CHEST, 2005, 128 (04) :2247-2261

[7] Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV [J].

Liu, Jia ;

Zheng, Xin ;

Tong, Qiaoxia ;

Li, Wei ;

Wang, Baoju ;

Sutter, Kathrin ;

Trilling, Mirko ;

Lu, Mengji ;

Dittmer, Ulf ;

Yang, Dongliang .

JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (05) :491-494

[8]

Mineo G, 2012, RADIOL MED, V117, P185, DOI 10.1007/s11547-011-0740-3

[9] Persistent Post-COVID-19 Interstitial Lung Disease An Observational Study of Corticosteroid Treatment [J].

Myall, Katherine Jane ;

Mukherjee, Bhashkar ;

Castanheira, Ana Margarida ;

Lam, Jodie L. ;

Benedetti, Giulia ;

Mak, Sze Mun ;

Preston, Rebecca ;

Thillai, Muhunthan ;

Dewar, Amy ;

Molyneaux, Philip L. ;

West, Alex G. .

ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (05) :799-806

[10] Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations [J].

Phua, Jason ;

Weng, Li ;

Ling, Lowell ;

Egi, Moritoki ;

Lim, Chae-Man ;

Divatia, Jigeeshu Vasishtha ;

Shrestha, Babu Raja ;

Arabi, Yaseen M. ;

Ng, Jensen ;

Gomersall, Charles D. ;

Nishimura, Masaji ;

Koh, Younsuck ;

Du, Bin .

LANCET RESPIRATORY MEDICINE, 2020, 8 (05) :506-517

← 1 2 →